Giovanni Erminio
Overview
Explore the profile of Giovanni Erminio including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
217
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Puglisi F, Soma R, Podda M, Vetrella S, Rabusin M, Tropia S, et al.
Front Pediatr
. 2022 Nov;
10:950911.
PMID: 36405824
Background: Neuroblastic tumors (NBTs) are the most common extra-cranial solid tumors of childhood. Neurofibromatosis type 1 (NF1) is the most common neurocutaneous disorder with a predisposition to tumors. The co-occurrence...
2.
Sorrentino S, Ash S, Haupt R, Plantaz D, Schiff I, Hero B, et al.
Front Pediatr
. 2022 Oct;
10:1023498.
PMID: 36299690
Introduction: Between 5 and 15% of children with neuroblastoma (NB) present with or develop spinal canal invasion (SCI). The majority of these children have symptoms of epidural compression of spinal...
3.
Esposti C, Iadarola B, Maestri S, Beltrami C, Lavezzari D, Morini M, et al.
Int J Mol Sci
. 2021 Apr;
22(7).
PMID: 33915956
Neuroblastoma (NB) is an aggressive infancy tumor, leading cause of death among preschool age diseases. Here we focused on characterization of exosomal DNA (exo-DNA) isolated from plasma cell-derived exosomes of...
4.
Parodi S, Sorrentino S, Di Cataldo A, Tondo A, Fagnani A, Perri P, et al.
Pediatr Blood Cancer
. 2021 Jan;
68(5):e28904.
PMID: 33459514
Purpose: Stage 4S neuroblastoma, a tumor affecting infants, is characterized by the capacity to regress spontaneously and high cure rate. About a third of these infants undergo tumor progression requiring...
5.
Avanzini S, Buffoni I, Gigliotti A, Parodi S, Paraboschi I, Inserra A, et al.
Pediatr Surg Int
. 2020 Oct;
37(1):37-47.
PMID: 33123764
Purpose: To clarify the role of primary tumor resection in stage 4S neuroblastoma. Methods: We investigated a cohort of 172 infants diagnosed with stage 4S neuroblastoma between 1994 and 2013....
6.
Lasorsa V, Cimmino F, Ognibene M, Mazzocco K, Erminio G, Morini M, et al.
NPJ Genom Med
. 2020 Apr;
5:18.
PMID: 32337068
Genomic aberrations of neuroblastoma occurring in late childhood and adolescence are still understudied. Publicly available DNA copy number profiles of 556 tumors (discovery set) and of 208 tumors obtained by...
7.
Bagnasco F, Caruso S, Andreano A, Valsecchi M, Jankovic M, Biondi A, et al.
Eur J Cancer
. 2019 Feb;
110:86-97.
PMID: 30772657
Introduction: Advances in paediatric oncology led to the increase in long-term survival, revealing the burden of therapy-related long-term side effects. We evaluated overall and cause-specific mortality in a large cohort...
8.
Parodi S, Pistorio A, Erminio G, Ognibene M, Morini M, Garaventa A, et al.
Pediatr Blood Cancer
. 2019 Jan;
66(5):e27635.
PMID: 30688024
Background: Neuroblastoma (NB), a pediatric tumor of the sympathetic nervous system, is characterized by very frequent chromosomal aberrations at the onset of the disease. Identification of further risk factors for...
9.
De Bernardi B, Di Cataldo A, Garaventa A, Massirio P, Viscardi E, Podda M, et al.
Ital J Pediatr
. 2019 Jan;
45(1):8.
PMID: 30634996
Background: Infants diagnosed with stage 4 s neuroblastoma commonly experience spontaneous disease regression, with few succumbing without response to therapy. We analyzed a large cohort of such infants enrolled in...
10.
Stigliani S, Morandi F, Persico L, Lagazio C, Erminio G, Scaruffi P, et al.
Oncotarget
. 2018 May;
9(27):19014-19025.
PMID: 29721180
The miRNA expression profiles of bone marrow resident cells from children with neuroblastoma were compared to that of healthy children. No significant difference was found between localized and metastatic neuroblastoma,...